Skip to content

Author

Dinglingge Cao

We have 3 of 18 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Development of a messenger RNA therapy for schizophrenia.

BACKGROUND Few gene-disease associations identified by human genetic studies lead to new drugs that advance to first-in-human trials. Schizophrenia exemplifies this translational gap: thousands of gene-disease associations have been reported, but antipsychotics act via mechanisms introduced in the 1950s. To close the g...

N. Simons, Vibhuti Patel, Hao-Yuan Li et al. · 0 citations
Aug 2026

Nitric oxide-assisted lipid nanoparticles amplify mRNA vaccine responses.

NO-assisted LNPs are established as a unique platform for potent mRNA delivery, which provides a new paradigm for overcoming endosomal barriers and improving the efficacy of mRNA vaccines.

Zheng-Wei Liu, Dinglingge Cao, Xu-Cheng Hou et al. · 0 citations
Open access Aug 2026

Overcoming the blood-brain barrier using central nervous system-accessing lipid nanoparticles for enhanced mRNA therapeutics.

This work designed, synthesized, and tested a series of ionizable lipids and formulated them into CNS-accessing lipid nanoparticles (CA LNPs) to deliver mRNA, and the lead candidate, CA2d LNP, demonstrated efficient mRNA delivery across the blood-brain barrier following intravenous injection.

Si-Yu Wang, Yi-Chen Zhong, Chang Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.